nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.201	0.303	CbGbCtD
Meprobamate—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.148	0.224	CbGbCtD
Meprobamate—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.148	0.224	CbGbCtD
Meprobamate—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0622	0.0939	CbGbCtD
Meprobamate—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0532	0.0802	CbGbCtD
Meprobamate—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0502	0.0757	CbGbCtD
Meprobamate—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.00997	0.0415	CcSEcCtD
Meprobamate—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.00716	0.0298	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00376	0.0156	CcSEcCtD
Meprobamate—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.0126	CcSEcCtD
Meprobamate—Lymphadenopathy—Salbutamol—chronic obstructive pulmonary disease	0.00299	0.0124	CcSEcCtD
Meprobamate—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00293	0.0122	CcSEcCtD
Meprobamate—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00288	0.012	CcSEcCtD
Meprobamate—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00283	0.0118	CcSEcCtD
Meprobamate—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00251	0.0105	CcSEcCtD
Meprobamate—Petechiae—Prednisolone—chronic obstructive pulmonary disease	0.00245	0.0102	CcSEcCtD
Meprobamate—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00997	CcSEcCtD
Meprobamate—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.00955	CcSEcCtD
Meprobamate—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.0023	0.00955	CcSEcCtD
Meprobamate—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00228	0.00949	CcSEcCtD
Meprobamate—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00226	0.00941	CcSEcCtD
Meprobamate—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00219	0.00912	CcSEcCtD
Meprobamate—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00902	CcSEcCtD
Meprobamate—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00207	0.0086	CcSEcCtD
Meprobamate—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00204	0.00848	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00202	0.00841	CcSEcCtD
Meprobamate—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.00817	CcSEcCtD
Meprobamate—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00196	0.00817	CcSEcCtD
Meprobamate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.00801	CcSEcCtD
Meprobamate—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00797	CcSEcCtD
Meprobamate—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.00785	CcSEcCtD
Meprobamate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00188	0.0078	CcSEcCtD
Meprobamate—GABRA6—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00186	0.0193	CbGpPWpGaD
Meprobamate—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00184	0.00766	CcSEcCtD
Meprobamate—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00765	CcSEcCtD
Meprobamate—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00765	CcSEcCtD
Meprobamate—GABRA4—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00184	0.019	CbGpPWpGaD
Meprobamate—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00183	0.0189	CbGpPWpGaD
Meprobamate—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00182	0.00758	CcSEcCtD
Meprobamate—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00752	CcSEcCtD
Meprobamate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00179	0.00744	CcSEcCtD
Meprobamate—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00178	0.00741	CcSEcCtD
Meprobamate—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.00178	0.0074	CcSEcCtD
Meprobamate—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.00737	CcSEcCtD
Meprobamate—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00174	0.00725	CcSEcCtD
Meprobamate—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.0072	CcSEcCtD
Meprobamate—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00173	0.0072	CcSEcCtD
Meprobamate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00173	0.00719	CcSEcCtD
Meprobamate—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00172	0.00714	CcSEcCtD
Meprobamate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.0017	0.00708	CcSEcCtD
Meprobamate—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.00694	CcSEcCtD
Meprobamate—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00167	0.00694	CcSEcCtD
Meprobamate—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00166	0.0172	CbGpPWpGaD
Meprobamate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00166	0.00692	CcSEcCtD
Meprobamate—GABRA6—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00166	0.0172	CbGpPWpGaD
Meprobamate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.00685	CcSEcCtD
Meprobamate—GABRA4—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00164	0.0169	CbGpPWpGaD
Meprobamate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00681	CcSEcCtD
Meprobamate—GABRA5—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00163	0.0169	CbGpPWpGaD
Meprobamate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00678	CcSEcCtD
Meprobamate—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00673	CcSEcCtD
Meprobamate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00668	CcSEcCtD
Meprobamate—GABRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0016	0.0166	CbGpPWpGaD
Meprobamate—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00658	CcSEcCtD
Meprobamate—GABRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00158	0.0163	CbGpPWpGaD
Meprobamate—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00655	CcSEcCtD
Meprobamate—GABRB3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00157	0.0162	CbGpPWpGaD
Meprobamate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.00646	CcSEcCtD
Meprobamate—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00154	0.0159	CbGpPWpGaD
Meprobamate—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00153	0.00636	CcSEcCtD
Meprobamate—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00622	CcSEcCtD
Meprobamate—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00622	CcSEcCtD
Meprobamate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00618	CcSEcCtD
Meprobamate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00618	CcSEcCtD
Meprobamate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00614	CcSEcCtD
Meprobamate—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00609	CcSEcCtD
Meprobamate—GABRA5—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00146	0.0151	CbGpPWpGaD
Meprobamate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00605	CcSEcCtD
Meprobamate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00598	CcSEcCtD
Meprobamate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00598	CcSEcCtD
Meprobamate—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00143	0.0148	CbGpPWpGaD
Meprobamate—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00587	CcSEcCtD
Meprobamate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00586	CcSEcCtD
Meprobamate—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00141	0.0145	CbGpPWpGaD
Meprobamate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00584	CcSEcCtD
Meprobamate—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0014	0.0144	CbGpPWpGaD
Meprobamate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00574	CcSEcCtD
Meprobamate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00573	CcSEcCtD
Meprobamate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00573	CcSEcCtD
Meprobamate—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00137	0.0142	CbGpPWpGaD
Meprobamate—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00136	0.0141	CbGpPWpGaD
Meprobamate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00564	CcSEcCtD
Meprobamate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00561	CcSEcCtD
Meprobamate—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00134	0.0139	CbGpPWpGaD
Meprobamate—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00133	0.0137	CbGpPWpGaD
Meprobamate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00552	CcSEcCtD
Meprobamate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00552	CcSEcCtD
Meprobamate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00551	CcSEcCtD
Meprobamate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00541	CcSEcCtD
Meprobamate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00539	CcSEcCtD
Meprobamate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00539	CcSEcCtD
Meprobamate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00534	CcSEcCtD
Meprobamate—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00523	CcSEcCtD
Meprobamate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00521	CcSEcCtD
Meprobamate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00516	CcSEcCtD
Meprobamate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00516	CcSEcCtD
Meprobamate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.00513	CcSEcCtD
Meprobamate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00513	CcSEcCtD
Meprobamate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00509	CcSEcCtD
Meprobamate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00504	CcSEcCtD
Meprobamate—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00121	0.0125	CbGpPWpGaD
Meprobamate—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.0012	0.0124	CbGpPWpGaD
Meprobamate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.00496	CcSEcCtD
Meprobamate—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00494	CcSEcCtD
Meprobamate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00491	CcSEcCtD
Meprobamate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00491	CcSEcCtD
Meprobamate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00487	CcSEcCtD
Meprobamate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00486	CcSEcCtD
Meprobamate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00484	CcSEcCtD
Meprobamate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00481	CcSEcCtD
Meprobamate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.0048	CcSEcCtD
Meprobamate—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00114	0.0118	CbGpPWpGaD
Meprobamate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00468	CcSEcCtD
Meprobamate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00463	CcSEcCtD
Meprobamate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00461	CcSEcCtD
Meprobamate—Purpura—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00459	CcSEcCtD
Meprobamate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00457	CcSEcCtD
Meprobamate—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00109	0.0113	CbGpPWpGaD
Meprobamate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00454	CcSEcCtD
Meprobamate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00452	CcSEcCtD
Meprobamate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00436	CcSEcCtD
Meprobamate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00436	CcSEcCtD
Meprobamate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00435	CcSEcCtD
Meprobamate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00431	CcSEcCtD
Meprobamate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00431	CcSEcCtD
Meprobamate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00429	CcSEcCtD
Meprobamate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00427	CcSEcCtD
Meprobamate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000991	0.00412	CcSEcCtD
Meprobamate—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000989	0.0102	CbGpPWpGaD
Meprobamate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000978	0.00407	CcSEcCtD
Meprobamate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000978	0.00407	CcSEcCtD
Meprobamate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000977	0.00406	CcSEcCtD
Meprobamate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000958	0.00398	CcSEcCtD
Meprobamate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000953	0.00396	CcSEcCtD
Meprobamate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000953	0.00396	CcSEcCtD
Meprobamate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000939	0.00391	CcSEcCtD
Meprobamate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000939	0.00391	CcSEcCtD
Meprobamate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000933	0.00388	CcSEcCtD
Meprobamate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000924	0.00384	CcSEcCtD
Meprobamate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00092	0.00383	CcSEcCtD
Meprobamate—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000911	0.00942	CbGpPWpGaD
Meprobamate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000908	0.00378	CcSEcCtD
Meprobamate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000908	0.00378	CcSEcCtD
Meprobamate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000904	0.00376	CcSEcCtD
Meprobamate—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0009	0.0093	CbGpPWpGaD
Meprobamate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000899	0.00374	CcSEcCtD
Meprobamate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00089	0.0037	CcSEcCtD
Meprobamate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000887	0.00369	CcSEcCtD
Meprobamate—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000878	0.00908	CbGpPWpGaD
Meprobamate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000878	0.00365	CcSEcCtD
Meprobamate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000878	0.00365	CcSEcCtD
Meprobamate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00086	0.00358	CcSEcCtD
Meprobamate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000858	0.00357	CcSEcCtD
Meprobamate—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000845	0.00873	CbGpPWpGaD
Meprobamate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000844	0.00351	CcSEcCtD
Meprobamate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000844	0.00351	CcSEcCtD
Meprobamate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000836	0.00348	CcSEcCtD
Meprobamate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000836	0.00348	CcSEcCtD
Meprobamate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000832	0.00346	CcSEcCtD
Meprobamate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000832	0.00346	CcSEcCtD
Meprobamate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000829	0.00345	CcSEcCtD
Meprobamate—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000827	0.00855	CbGpPWpGaD
Meprobamate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000827	0.00344	CcSEcCtD
Meprobamate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000819	0.00341	CcSEcCtD
Meprobamate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000815	0.00339	CcSEcCtD
Meprobamate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000805	0.00335	CcSEcCtD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000799	0.00826	CbGpPWpGaD
Meprobamate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000797	0.00331	CcSEcCtD
Meprobamate—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000796	0.00822	CbGpPWpGaD
Meprobamate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000791	0.00329	CcSEcCtD
Meprobamate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00079	0.00329	CcSEcCtD
Meprobamate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.00328	CcSEcCtD
Meprobamate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000789	0.00328	CcSEcCtD
Meprobamate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000789	0.00328	CcSEcCtD
Meprobamate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.00327	CcSEcCtD
Meprobamate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000785	0.00811	CbGpPWpGaD
Meprobamate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000774	0.00322	CcSEcCtD
Meprobamate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000772	0.00321	CcSEcCtD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000771	0.00797	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000766	0.00792	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000752	0.00778	CbGpPWpGaD
Meprobamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000745	0.0077	CbGpPWpGaD
Meprobamate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.0031	CcSEcCtD
Meprobamate—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000743	0.00768	CbGpPWpGaD
Meprobamate—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000733	0.00758	CbGpPWpGaD
Meprobamate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000719	0.00299	CcSEcCtD
Meprobamate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000707	0.00294	CcSEcCtD
Meprobamate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000702	0.00292	CcSEcCtD
Meprobamate—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000685	0.00708	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000676	0.00699	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000658	0.0068	CbGpPWpGaD
Meprobamate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000657	0.00273	CcSEcCtD
Meprobamate—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000653	0.00675	CbGpPWpGaD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000652	0.00674	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000648	0.0067	CbGpPWpGaD
Meprobamate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000646	0.00268	CcSEcCtD
Meprobamate—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00064	0.00662	CbGpPWpGaD
Meprobamate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00064	0.00661	CbGpPWpGaD
Meprobamate—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000638	0.0066	CbGpPWpGaD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000629	0.0065	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000625	0.00646	CbGpPWpGaD
Meprobamate—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000614	0.00635	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000613	0.00634	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000601	0.00621	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00059	0.0061	CbGpPWpGaD
Meprobamate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000588	0.00245	CcSEcCtD
Meprobamate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000585	0.00243	CcSEcCtD
Meprobamate—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000585	0.00604	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00058	0.00599	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000578	0.00597	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000576	0.00595	CbGpPWpGaD
Meprobamate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000575	0.00239	CcSEcCtD
Meprobamate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000574	0.00239	CcSEcCtD
Meprobamate—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00057	0.0059	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000569	0.00588	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000566	0.00585	CbGpPWpGaD
Meprobamate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000563	0.00234	CcSEcCtD
Meprobamate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000561	0.0058	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000558	0.00577	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000558	0.00577	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000551	0.0057	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000549	0.00567	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000545	0.00564	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000536	0.00554	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000535	0.00553	CbGpPWpGaD
Meprobamate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00053	0.0022	CcSEcCtD
Meprobamate—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000525	0.00542	CbGpPWpGaD
Meprobamate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000522	0.00217	CcSEcCtD
Meprobamate—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000518	0.00536	CbGpPWpGaD
Meprobamate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000514	0.00214	CcSEcCtD
Meprobamate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00051	0.00212	CcSEcCtD
Meprobamate—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000507	0.00524	CbGpPWpGaD
Meprobamate—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000506	0.00523	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000498	0.00515	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000494	0.00511	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00049	0.00506	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000489	0.00506	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000486	0.00502	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000484	0.005	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000481	0.00497	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000477	0.00493	CbGpPWpGaD
Meprobamate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000475	0.00198	CcSEcCtD
Meprobamate—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000474	0.0049	CbGpPWpGaD
Meprobamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000473	0.00489	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000473	0.00489	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00047	0.00485	CbGpPWpGaD
Meprobamate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000469	0.00195	CcSEcCtD
Meprobamate—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000468	0.00484	CbGpPWpGaD
Meprobamate—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000467	0.00482	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000461	0.00477	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00046	0.00476	CbGpPWpGaD
Meprobamate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000453	0.00188	CcSEcCtD
Meprobamate—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000452	0.00467	CbGpPWpGaD
Meprobamate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00045	0.00187	CcSEcCtD
Meprobamate—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000444	0.00459	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000441	0.00456	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000433	0.00448	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000428	0.00442	CbGpPWpGaD
Meprobamate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00178	CcSEcCtD
Meprobamate—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000425	0.00439	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000422	0.00437	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000422	0.00436	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000417	0.00431	CbGpPWpGaD
Meprobamate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00172	CcSEcCtD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000405	0.00419	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000403	0.00417	CbGpPWpGaD
Meprobamate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000385	0.0016	CcSEcCtD
Meprobamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000383	0.00396	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000379	0.00392	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000375	0.00388	CbGpPWpGaD
Meprobamate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00156	CcSEcCtD
Meprobamate—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000373	0.00386	CbGpPWpGaD
Meprobamate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00037	0.00154	CcSEcCtD
Meprobamate—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000369	0.00381	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000365	0.00378	CbGpPWpGaD
Meprobamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000365	0.00377	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000362	0.00374	CbGpPWpGaD
Meprobamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00036	0.00372	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00036	0.00372	CbGpPWpGaD
Meprobamate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000357	0.00149	CcSEcCtD
Meprobamate—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000353	0.00365	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.00035	0.00362	CbGpPWpGaD
Meprobamate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00144	CcSEcCtD
Meprobamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000344	0.00355	CbGpPWpGaD
Meprobamate—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000339	0.0035	CbGpPWpGaD
Meprobamate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000332	0.00138	CcSEcCtD
Meprobamate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00137	CcSEcCtD
Meprobamate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00136	CcSEcCtD
Meprobamate—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000322	0.00333	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000319	0.0033	CbGpPWpGaD
Meprobamate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00129	CcSEcCtD
Meprobamate—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000309	0.00319	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000307	0.00317	CbGpPWpGaD
Meprobamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000296	0.00306	CbGpPWpGaD
Meprobamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000278	0.00288	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000271	0.0028	CbGpPWpGaD
Meprobamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000265	0.00274	CbGpPWpGaD
Meprobamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.0027	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000256	0.00264	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000253	0.00262	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000245	0.00253	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000242	0.0025	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000235	0.00243	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000224	0.00232	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000219	0.00226	CbGpPWpGaD
Meprobamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.00222	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000209	0.00216	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000208	0.00215	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.0021	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000201	0.00208	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000194	0.002	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000189	0.00195	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000187	0.00193	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00017	0.00176	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000167	0.00173	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000163	0.00169	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00162	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000156	0.00161	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.0016	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000154	0.00159	CbGpPWpGaD
Meprobamate—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00153	CbGpPWpGaD
Meprobamate—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00151	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000138	0.00143	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000133	0.00137	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000133	0.00137	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000131	0.00135	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000129	0.00134	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000127	0.00131	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000126	0.0013	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00012	0.00124	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.00012	0.00124	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000119	0.00123	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000119	0.00123	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000115	0.00119	CbGpPWpGaD
Meprobamate—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00118	CbGpPWpGaD
Meprobamate—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00116	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000112	0.00116	CbGpPWpGaD
Meprobamate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000112	0.00116	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000112	0.00115	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00011	0.00113	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000108	0.00111	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000107	0.00111	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000105	0.00109	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	9.72e-05	0.00101	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.64e-05	0.000997	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	9.18e-05	0.000949	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.18e-05	0.000949	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	8.96e-05	0.000926	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	8.92e-05	0.000923	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.33e-05	0.000861	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.88e-05	0.000815	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.78e-05	0.000804	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	7.67e-05	0.000793	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.64e-05	0.000789	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.54e-05	0.000779	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.13e-05	0.000737	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.7e-05	0.000692	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.58e-05	0.00068	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.55e-05	0.000677	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.46e-05	0.000668	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.42e-05	0.000664	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.31e-05	0.000652	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.08e-05	0.000629	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.03e-05	0.000624	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.94e-05	0.000614	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	5.92e-05	0.000612	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.77e-05	0.000597	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.51e-05	0.00057	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.5e-05	0.000569	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.37e-05	0.000555	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.8e-05	0.000496	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.6e-05	0.000476	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.4e-05	0.000455	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.38e-05	0.000453	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.32e-05	0.000446	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.19e-05	0.000433	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.14e-05	0.000428	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.11e-05	0.000425	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.78e-05	0.000391	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.63e-05	0.000375	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.48e-05	0.00036	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.23e-05	0.000334	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	3.19e-05	0.00033	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.15e-05	0.000326	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.12e-05	0.000322	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.98e-05	0.000308	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.92e-05	0.000301	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.9e-05	0.0003	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.86e-05	0.000296	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.85e-05	0.000294	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.76e-05	0.000286	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.69e-05	0.000278	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.67e-05	0.000276	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.62e-05	0.000271	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.53e-05	0.000262	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.24e-05	0.000232	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.21e-05	0.000228	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.19e-05	0.000226	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.16e-05	0.000223	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.06e-05	0.000213	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.01e-05	0.000208	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.95e-05	0.000202	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.000197	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.72e-05	0.000178	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.64e-05	0.00017	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000137	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.29e-05	0.000134	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000131	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000128	CbGpPWpGaD
